ALLMedicine™ Adrenocortical Carcinoma Center
Research & Reviews 585 results
https://doi.org/10.1001/jamasurg.2021.3646
JAMA Surgery; Pearlstein SS, Conroy PC et. al.
Sep 9th, 2021 - Evaluation of Necrosis as a Diagnostic and Prognostic Indicator in Adrenocortical Carcinoma.|2021|Pearlstein SS,Conroy PC,Menut KC,Kim J,Graves CE,|
https://doi.org/10.1007/s10147-021-02021-8 10.1007/s00268-005-0329-x 10.1016/j.ejca.2013.02.034 10.1530/EJE-18-0608 10.1056/NEJMoa1200966 10.1136/bmjspcare-2018-001568 10.1530/EJE-15-0354 10.1007/s11102-015-0645-6 10.21037/jtd.2019.08.63 10.1016/j.ejca.2011.06.027 10.1016/j.ejca.2008.10.026 10.1530/EJE-17-0452 10.1677/ERC-08-0103 10.1530/edm-16-0061 10.1007/s12020-017-1428-9 10.1530/EJE-18-0450 10.1016/j.eururo.2013.11.006 10.1001/jamasurg.2015.4516 10.1002/1097-0142(20010915)92:6<1385::aid-cncr1461>3.0.co;2-2 10.1210/jc.2010-2676 10.3390/biomedicines9020174 10.1016/S1470-2045(15)70081-1 10.1210/jc.2013-2298 10.1530/EJE-11-0918 10.1186/s40425-018-0424-9 10.1530/EC-18-0398 10.1677/ERC-08-0224 10.1677/ERC-09-0341 10.1530/ERC-17-0095 10.1530/EJE-17-0788
International Journal of Clinical Oncology; Uchihara M, Tanioka M et. al.
Sep 2nd, 2021 - Adrenocortical carcinoma (ACC) is a rare and aggressive disease that is often diagnosed at an advanced stage. There is no standard treatment for metastatic ACC; EDP-M (etoposide, doxorubicin, and cisplatin plus mitotane) is one treatment option. A...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393459
BMC Cancer; Zhang F, Liu Z et. al.
Aug 28th, 2021 - Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with a poor prognosis. Given the limited treatment options, prognostic assessment of ACC is increasingly crucial. In this study, we aim to assess the correlation between preoperati...
https://doi.org/10.1080/08941939.2021.1968981
Journal of Investigative Surgery : the Official Journal O... Wang W, Chang G et. al.
Aug 27th, 2021 - Adrenocortical carcinoma (ACC) is extremely rare in elderly patients. Thus, this study aimed to identify the incidence rate and develop nomogram models for predicting survival in elderly ACC patients. Data of ACC patients aged >60 years from 1975 ...
https://doi.org/10.1002/jso.26639
Journal of Surgical Oncology; Naffouje SA, Sabesan A et. al.
Aug 24th, 2021 - The standard diagnosis for adrenocortical carcinoma (ACC) is clinical diagnosis (CD) based on radiographic and biochemical studies. Biopsy diagnosis (BD) is seldom required for the suspicion of secondary malignancy. We aim to study the impact of B...
Guidelines 1 results
https://doi.org/10.1210/jc.2008-0104
The Journal of Clinical Endocrinology and Metabolism; Funder JW, Carey RM et. al.
Jun 17th, 2008 - Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, si...
News 16 results
https://www.medscape.com/viewarticle/934790
Jul 29th, 2020 - A strategy that includes a urine steroid test along with imaging characteristics and tumor size criteria can significantly improve the challenging diagnosis of adrenocortical cancer, helping to avoid unnecessary, and often unsuccessful, further im...
https://reference.medscape.com/viewarticle/904250
Nov 5th, 2018 - Clinical practice guidelines for the management of adrenocortical carcinoma in adults were released in October 2018 by the European Society of Endocrinology.[1] Diagnosis Perform a detailed hormonal workup of all patients with suspected adrenocort...
https://reference.staging.medscape.com/viewarticle/904250
Nov 5th, 2018 - Clinical practice guidelines for the management of adrenocortical carcinoma in adults were released in October 2018 by the European Society of Endocrinology.[1] Diagnosis Perform a detailed hormonal workup of all patients with suspected adrenocort...
https://www.medscape.com/viewarticle/900291_6
Aug 9th, 2018 - Oncology Adrenocortical Carcinoma Advanced Breast Cancer Cancer Pain Management Constipation in Advanced Cancer HER2+ Advanced Breast Cancer
https://www.mdedge.com/internalmedicine/article/109105/pituitary-thyroid-adrenal-disorders/resection-recurrence-shows
Richard Mark Kirkner
May 25th, 2016 - BALTIMORE – Patients who have recurrent adrenocortical carcinoma appear to have one option to increase their survival: surgery that includes complete tumor resection – but it may a viable path only if the recurrence occurred a year or more after t.
